Board of Directors

  • Jeff Ronaldi

    Chief Executive Officer, Director

    Jeff Ronaldi has served as the Company's Chief Executive Officer and director since July 1, 2013. Mr. Ronaldi had previously served as Lexington Technology Group, Inc.'s Chief Executive Officer since November 9, 2012. He also has served since July 2011 as Managing Director at HPR Capital, LLC; since January 2008 he has also served as Managing Partner of CTD Group, LLC and since June 2005, he has served as Managing Director of SSL Services, LLC. From November 2008 to November 2010, he served as Chief Executive Officer at Turtle Bay Technologies, an intellectual property management firm that provides strategic capital, asset management services and guidance for intellectual property owners. Mr. Ronaldi's experience with Turtle Bay Technologies and management of intellectual property qualifies him to serve on our Board of Directors.

  • Heng Fai Ambrose Chan


    Heng Fai Amrose Chan has served as a director of the Company since February 12, 2017. Mr. Chan is an expert in banking and finance, with years of experience in the industry. Mr. Chan has restructured 35 companies in various industries and countries in the past 40 years. Mr. Chan currently serves as the Chief Executive Officer of Singapore eDevelopment Limited (SED), a publicly traded company on the Singapore Stock Exchange. He also serves as a director of BMI Capital Partners International Ltd., a wholly-owned subsidiary of SED. Mr. Chan also serves on the board of Holista CollTech Limited, a publicly traded company listed on the Australian Securities Exchange.

    Mr. Chan formerly served as (i) Managing Chairman of Heng Fai Enterprises Limited (now known as ZH International Holdings Limited) which trades on the Hong Kong Stock Exchange; (ii) the Managing Director of SGX Catalist-listed SingHaiyi Group Ltd., which under his leadership, transformed from a failing store-fixed business provider with net asset value of less than $10 million into a property trading and investment company and finally to a property development company with net asset value over $150 million before Mr. Chan ceded controlling interest in late 2012; (iii) the Executive Chairman of China Gas Holdings Limited, a formerly failing fashion retail company listed on the Hong Kong Stock Exchange, which under his direction, was restructured to become one of the few large participants in the investment in and operation of city gas pipeline infrastructure in China; (iv) a director of Global Med Technologies, Inc., a medical company listed on NASDAQ engaged in the design, development, marketing and support information for management software products for healthcare-related facilities; (v) a director of Skywest Limited, an ASX-listed airline company; and (vi) the Chairman and Director of American Pacific Bank.

    In 1987, Mr. Chan acquired American Pacific Bank, a full-service U.S. commercial bank, and brought it out of bankruptcy. He recapitalized, refocused and grew the bank's operations. Under his guidance it became a NASDAQ-listed high asset quality bank with zero loan losses for over five consecutive years before it was ultimately bought and merged into Riverview Bancorp Inc. Prior to its acquisition and merger, it was ranked #13 by the Seattle Times “Annual Northwest's Top 100 Public Companies”, and ranked #6 in Oregon state, ahead of names such as Nike, Microsoft, Costco, AT&T Wireless and Mr. Chan's international business contacts and experience qualifies him to serve on our Board of Directors.

  • Joseph Sanders


    Joseph Sanders has served as a director of the Company since October 1, 2015. Mr. Sanders graduated with a BS in Business Administration and Finance from the University of Southern California and went on to receive an MBA in Finance from Loyola Marymount University. He received his license as a financial advisor in 1981, and then worked as a financial analyst at Hughes Aircraft for two years. Thereafter, between 1983 and 2001, Mr. Sanders served as a financial advisor at Dean Witter, EF Hutton, Shearson Lehman, Bateman Eichler, AG Edwards, Sutro and Morgan Stanley. Since 2001, Mr. Sanders has served as a Registered Investment Advisor with a firm formerly known as Newport Coast Securities, which was recently acquired by WestPark Capital. All of this experience qualifies him to serve on our Board of Directors.

  • Pamela Avallone


    Pamela Avallone is a Registered U.S. Patent Attorney and medical doctor with over 25 years of combined scientific, medical and legal experience. Throughout her legal career, Dr. Avallone's practice has focused on intellectual property litigation and transactions, science and technology law, and regulatory matters with experience as both in-house and outside counsel. Dr. Avallone is a Consultant for Brickell Key Asset Management, LLC (“BKI”) and previously served as Director of Intellectual Property Investments and Head of Underwriting for BKI's predecessor Juridica Asset Management (US) Inc. (2014-2016). Prior to Juridica, Dr. Avallone was a shareholder at the law firm Polsinelli P.C. (New York, 2012-2014), and an attorney at the law firms of Edwards Wildman Palmer LLP (Boston, 2007-2012), and Frommer Lawrence & Haug LLP (New York, 2002-2005). Dr. Avallone was Intellectual Property Counsel for Rembrandt IP Management (2005-2007), where she managed IP litigation and acquisitions in the telecommunications, semiconductor, medical device, and healthcare sectors. During her Boston-based law firm practice, Dr. Avallone concurrently served as in-house counsel for Cequent Pharmaceuticals, Inc. (Vice President, Intellectual Property and Legal Affairs, 2007-2010, after which Cequent merged with MDRNA, Inc. to form Marina Biotech Inc.) and GnuBIO, Inc. (Vice President, Intellectual Property and Legal Affairs, 2007-2014, after which GnuBIO was acquired by Bio-Rad Laboratories, Inc.).

    Prior to practicing law, Dr. Avallone worked in clinical research in cardiothoracic surgery (Yale-New Haven Hospital, 1991-1995), as a Research Assistant in the Department of Discovery Technologies for Neurogen Corporation (1997-1998), and as a Research Scientist in the Department of Research Technologies for Bayer Corporation (1998-2001).

    Dr. Avallone earned her J.D. with a concentration in intellectual property and communications law from Yeshiva University, Cardozo School of Law, her M.D. from University of Medicine and Health Sciences, her M.S. from Southern Connecticut State University, and her B.S. (cum laude) from University of New Haven. Dr. Avallone's expertise in patent and transactional law and IP finance qualifies her to serve on our board of directors.

  • Clark A. Marcus


    Clark A. Marcus is Chairman of the Board and Chief Executive Officer of Advanzeon Solutions, Inc. located in Tampa, Florida, positions he has held since May 2009. From September 1993 until October 2008, Mr. Marcus served as Chairman of the Board of The Amacore Group, Inc. (f/k/a Eye Care International, Inc.), and he formerly served as Amacore's Chief Executive Officer and President.

    Mr. Marcus currently serves on the Board of Directors for America's Agenda: Health Care for All. He also serves on the Corporate Leadership Advisory Council to the U.S. Chamber of Commerce. Mr. Marcus previously served as a member of the American Academy of Ophthalmology's Corporate Advisory Council; participated as guest lecturer at various national healthcare conferences and has authored numerous healthcare related articles published in various national healthcare publications such as “Managed Care Weekly” and “Managing Employee Health Benefits.” Mr. Marcus has been a practicing attorney since 1968 and was a Partner in the New York law firms of Victor & Marcus and Marcus & Marcus. In his general practice, Mr. Marcus represented clients engaged in several corporate financing and international transactions and investment ventures. Mr. Marcus's legal expertise and experience in leading various companies qualify him to serve on our Board of Directors.

  • Frank D. Heuszel


    Mr. Heuszel is a practicing attorney, a Certified Public Accountant, and a Certified Internal Auditor, and has over 39 years of experience in accounting and finance matters. Mr. Heuszel's law practice focuses on the regulation and operation of banks, corporate restructures, and mergers and acquisitions. The Company believes that Mr. Heuszel's experience and expertise in the areas of evaluating financial statements and complex financial transactions will be beneficial to the Company. Mr. Heuszel qualifies as an independent director and will also serve on the Company's Audit Committee.